Acadian Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Acadian Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-57,481	Closed	-$1M	–	2452
2020 Q4	$1M	Sell	57,481 -3,349	-6%	-$47K	﹤0.01%	990
2020 Q3	$713K	Sell	60,830 -41,188	-40%	-$547K	﹤0.01%	1022
2020 Q2	$1.33M	Sell	102,018 -71,601	-41%	-$860K	0.01%	865
2020 Q1	$1.61M	Buy	173,619 +36,942	+27%	+$516K	0.01%	666
2019 Q4	$2.27M	Buy	136,677 +106,268	+349%	+$1.72M	0.01%	648
2019 Q3	$505K	Sell	30,409 -15,769	-34%	-$218K	﹤0.01%	1083
2019 Q2	$636K	Buy	46,178 +12,209	+36%	+$187K	﹤0.01%	936
2019 Q1	$586K	Buy	33,969 +30,801	+972%	+$487K	﹤0.01%	1055
2018 Q4	$40K	Sell	3,168 -1,716	-35%	-$26K	﹤0.01%	1462
2018 Q3	$79K	Buy	+4,884	New	+$69.8K	﹤0.01%	1267

Acadian Asset Management's OXFD Position: Q1 2021 in Review

Acadian Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 57,481 shares — an estimated $1M sold.

Acadian Asset Management first reported a position in OXFD in Q3 2018 and held it in 10 quarters. The position peaked at $2.27M in Q4 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Acadian Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Acadian Asset Management sold 57,481 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1M.
Acadian Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2018 and held it in 10 quarters.
Acadian Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.27M in Q4 2019.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.